India Pharma Outlook Team | Tuesday, 17 October 2023
In India, Abbott has released a new vascular imaging platform driven by Ultreon 1.0 Software. This cutting-edge intra-vascular imaging software blends optical coherence tomography (OCT) with the power of artificial intelligence (AI), giving physicians a full image of blood flow and blockages within coronary arteries. The cutting-edge imaging software can automatically distinguish between calcified and noncalcified blockages, determine the severity of calcium-based obstructions, and assess vessel diameter .
Furthermore, it assists physicians in guiding precise stent deployment, ensuring optimal stent expansion and apposition, and displaying data instantly to improve precision during coronary stenting procedures,as per pharmabiz. Unlike conventional angiography, Abbott's OCT technology uses near-infrared light to offer high-definition, precise imaging from within a blood vessel, allowing physicians to gather information from even the most intricate human anatomy .
The program supports a streamlined workflow that a llows for more accurate and faster decision-making , as well as less ambiguity, allowing you to focus on what matters most: caring for the patient and increasing their quality of life. With the release of Ultreon 1.0 Software, Abbott is extending its use of OCT technology to assist physicians in making better treatment decisions for their patients. According to recent research, physicians changed their treatment plan in 88% of coronary artery blockages based on new information supplied by OCT when used in conjunction with MLD MAX, a novel workflow that helps guide stenting decisions and provides physicians with treatment methods to optimize stent placement. "This new OCT software gives us an automated and comprehensive view of the coronary arteries." This undoubtedly aids decision-making while directing precise stent placement," said Dr. Ankur Phatarpekar of Symbiosis Speciality Hospital in Mumbai. "These types of technologies are instrumental in providing the best care for our patients."